Astria Therapeutics, Inc. (ATXS)
12.86
-0.06
(-0.43%)
USD |
NASDAQ |
Dec 16, 16:00
12.86
0.00 (0.00%)
After-Hours: 20:00
Astria Therapeutics Research and Development Expense (Annual): 77.11M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 173.39M |
| Johnson & Johnson | 17.26B |
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| CorMedix, Inc. | 3.942M |
| Rezolute, Inc. | 61.53M |